Literature DB >> 25561730

Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.

Mi Jin Moon1, Yoo-Na Lee1, Sumi Park1, Arfaxad Reyes-Alcaraz1, Jong-Ik Hwang1, Robert Peter Millar2, Han Choe3, Jae Young Seong4.   

Abstract

Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis through its receptor GLP1R. Due to its multiple beneficial effects, GLP-1 has gained great attention for treatment of type 2 diabetes and obesity. However, little is known about the molecular mechanism underlying the interaction of GLP-1 with the heptahelical core domain of GLP1R conferring high affinity ligand binding and ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R, we determined that the evolutionarily conserved amino acid residue Arg(380) flanked by hydrophobic Leu(379) and Phe(381) in extracellular loop 3 (ECL3) may have an interaction with Asp(9) and Gly(4) of the GLP-1 peptide. The molecular modeling study showed that Ile(196) at transmembrane helix 2, Met(233) at ECL1, and Asn(302) at ECL2 of GLP1R have contacts with His(1) and Thr(7) of GLP-1. This study may shed light on the mechanism underlying high affinity interaction between the ligand and the binding pocket that is formed by these conserved residues in the GLP1R core domain.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Diabetes; Evolution; G Protein-coupled Receptor (GPCR); GLP-1; GLP1R; Ligand Selectivity; Molecular Modeling; Signaling

Mesh:

Substances:

Year:  2015        PMID: 25561730      PMCID: PMC4342481          DOI: 10.1074/jbc.M114.612606

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

3.  Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.

Authors:  Quan Chen; Delia I Pinon; Laurence J Miller; Maoqing Dong
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

4.  Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

Authors:  K Coopman; R Wallis; G Robb; A J H Brown; G F Wilkinson; D Timms; G B Willars
Journal:  Mol Endocrinol       Date:  2011-08-25

5.  Discovery of a novel glucagon-like peptide (GCGL) and its receptor (GCGLR) in chickens: evidence for the existence of GCGL and GCGLR genes in nonmammalian vertebrates.

Authors:  Yajun Wang; Fengyan Meng; Yu Zhong; Guian Huang; Juan Li
Journal:  Endocrinology       Date:  2012-09-26       Impact factor: 4.736

6.  Structural determinants for activity of glucagon-like peptide-2.

Authors:  M P DaCambra; B Yusta; M Sumner-Smith; A Crivici; D J Drucker; P L Brubaker
Journal:  Biochemistry       Date:  2000-08-01       Impact factor: 3.162

Review 7.  Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.

Authors:  James F List; Joel F Habener
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-06       Impact factor: 4.310

8.  Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists.

Authors:  Fu Lin; Renxiao Wang
Journal:  J Mol Model       Date:  2008-10-22       Impact factor: 1.810

9.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Authors:  T J Kieffer; C H McIntosh; R A Pederson
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Authors:  Kyle W Sloop; Francis S Willard; Martin B Brenner; James Ficorilli; Kathleen Valasek; Aaron D Showalter; Thomas B Farb; Julia X C Cao; Amy L Cox; M Dodson Michael; Sonia Maria Gutierrez Sanfeliciano; Mark J Tebbe; Michael J Coghlan
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

View more
  17 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Structure of the glucagon receptor in complex with a glucagon analogue.

Authors:  Haonan Zhang; Anna Qiao; Linlin Yang; Ned Van Eps; Klaus S Frederiksen; Dehua Yang; Antao Dai; Xiaoqing Cai; Hui Zhang; Cuiying Yi; Can Cao; Lingli He; Huaiyu Yang; Jesper Lau; Oliver P Ernst; Michael A Hanson; Raymond C Stevens; Ming-Wei Wang; Steffen Reedtz-Runge; Hualiang Jiang; Qiang Zhao; Beili Wu
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

4.  Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).

Authors:  Dehua Yang; Chris de Graaf; Linlin Yang; Gaojie Song; Antao Dai; Xiaoqing Cai; Yang Feng; Steffen Reedtz-Runge; Michael A Hanson; Huaiyu Yang; Hualiang Jiang; Raymond C Stevens; Ming-Wei Wang
Journal:  J Biol Chem       Date:  2016-04-08       Impact factor: 5.157

5.  Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Alisa Glukhova; Sebastian G B Furness; Peishen Zhao; Lachlan Clydesdale; Cassandra Koole; Tin T Truong; David M Thal; Saifei Lei; Mazdak Radjainia; Radostin Danev; Wolfgang Baumeister; Ming-Wei Wang; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton; Denise Wootten
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

6.  Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists.

Authors:  Sanaz Darbalaei; Ru-Lue Chang; Qing-Tong Zhou; Yan Chen; An-Tao Dai; Ming-Wei Wang; De-Hua Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-11       Impact factor: 7.169

7.  Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Authors:  Ali Jazayeri; Mathieu Rappas; Alastair J H Brown; James Kean; James C Errey; Nathan J Robertson; Cédric Fiez-Vandal; Stephen P Andrews; Miles Congreve; Andrea Bortolato; Jonathan S Mason; Asma H Baig; Iryna Teobald; Andrew S Doré; Malcolm Weir; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

8.  A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures.

Authors:  Denise Wootten; Christopher A Reynolds; Cassandra Koole; Kevin J Smith; Juan C Mobarec; John Simms; Tezz Quon; Thomas Coudrat; Sebastian G B Furness; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2015-12-23       Impact factor: 4.436

9.  Mutational Landscape of the Proglucagon-Derived Peptides.

Authors:  Peter Lindquist; Jakob S Madsen; Hans Bräuner-Osborne; Mette M Rosenkilde; Alexander S Hauser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

10.  Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.

Authors:  Ana B Bueno; Aaron D Showalter; David B Wainscott; Cynthia Stutsman; Aranzazu Marín; James Ficorilli; Over Cabrera; Francis S Willard; Kyle W Sloop
Journal:  J Biol Chem       Date:  2016-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.